A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

Metformin is the main first-line drug used to treat type 2 diabetes, but a new study on monkeys suggests it could one day be ...

Tandem Diabetes Care ( TNDM 4.25%) had some encouraging news to report on the regulatory front Thursday, and after it hit the ...

A new study has revealed a startling gap in prenatal care, showing that a commonly used screening method for this condition ...

Researchers have discovered that remodeling of extracellular matrix (ECM) in the hypothalamus, specifically around AgRP ...

For people with type 1 diabetes, management burden including suboptimal insulin preparations remains a major barrier to ...

It's unclear whether the small increased risks of type 2 diabetes highlighted in this red-meat research hold any true ...

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

One of the most common diabetes drugs, metformin, might deliver an added bonus: Lowering users' odds for Long COVID ...

Understanding and addressing the long-term implications of GDM is essential for the well-being of both mothers and their families.

Neuropathy and retinopathy are positively associated with moderate/severe periodontitis, according to a study published ...

A recent study suggests that a class of diabetes medications could be linked to a reduced risk of developing dementia ...